Back

Role of cardiac magnetic resonance, endomyocardial biopsy and cardiac-specific PET in the diagnosis of inflammatory cardiomyopathy

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - diagnostic methods 1 Imaging HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Kyeong-Hyeon Chun

NHIC Ilsan Hospital, Goyang (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Prediction of major adverse cardiovascular events in heart failure patients using face recognition: preliminary feasibility data of the CardioMIRROR trial
Doctor J. Alvarez-Garcia (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Right ventricular myocardial work: a novel echocardiographic approach to characterizing right ventricular function in the presence of tricuspid regurgitation
Doctor C. Bourg (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Left atrial mechanical function and clinical outcomes in patients with mitral annular calcification
Assistant Professor K. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Right ventricular to pulmonary artery coupling is the best predictor of the outcome in patients with heart failure with reduced ejection fraction and secondary mitral regurgitation
Doctor D. Hadareanu (Craiova, RO)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic value of myocardial work analysis in a low-risk community-based cohort
Doctor F. Zhubi Bakija (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - diagnostic methods 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The role of fluorodeoxyglucose-positron emission tomography imaging in suspected inflammatory cardiomyopathy
thumbnail
Congress Presentation
Immunomodulation to target biopsy-proven myocardial inflammation in genetic cardiomyopathies: a pilot report
thumbnail
Congress Presentation
The role of 18fluorine-fluorodeoxyglucose positron emission tomography in the diagnosis, follow-up, and regulation of treatment in patients with cardiac sarcoidosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources